Ever wondered about the unsung heroes of the healthcare system? The ones who make sure your medical bills are accurate, ...

Sanuwave’s growth prospects are defined by a massive TAM and a historic regulatory tailwind that is currently dismantling its primary competition. Read more here.

Cheelcare has received Pricing, Data Analysis and Coding (PDAC) verification for its Companion power assist device, confirming reimbursement eligibility for Medicare and Medicaid under HCPCS code E098 ...

The new cvi42 v6.4 release expands Circle CVI’s all-in-one solution, delivering advanced MR automation, comprehensive coronary plaque, PCAT, ...

The gender reassignment surgery market surges ahead with explosive growth, propelled by booming Male-to-Female demand, North ...

Investing.com -- Inspire Medical Systems (NYSE:INSP) stock fell 12.6% Thursday after the Centers for Medicare & Medicaid ...

Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology ...

One Platform for Every Advanced Cardiac Imaging Need.The new cvi42 v6.4 release expands Circle CVI's all-in-one solution, delivering advanced MR automation, comprehensive ...

To ensure that no patient is left behind in receiving this potentially life-saving therapy, Mesoblast has established a patient access hub termed MyMesoblast™, where Ryoncil ® is available for ...

JotPsych, creator of the leading AI scribe for behavioral health, today announced the launch of JotAudit, an audit-intelligence platform that fundamentally rewrites how behavioral-health clinics ...

Levee Medical(R) , a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its ...

(Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including ...